Connect Sign In
2014677
Expanded Carrier Screen by Next Generation Sequencing with Fragile X
ECS SEQ FX
Ordering Recommendation
Refer to "Additional Technical Information" document.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Lavender (EDTA).
Specimen Preparation
Transport 4 mL whole blood. (Min: 1 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Remarks
Patient history form is required.
Stability
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: Unacceptable
Methodology
Massively Parallel Sequencing / Polymerase Chain Reaction (PCR)
Performed
Varies
Reported
17-21 days
Reference Interval
By report
Interpretive Data
Compliance Category
Performed by non-ARUP Laboratory
Note
Compare to Foresight Carrier Screen.
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
81479
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2014678 | EER Expanded Carrier SCRN NGS w/FRAG X | 11526-1 |
| 2014679 | Expanded Carrier SCRN NGS w/FRAG X | 53039-4 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Expanded Carrier Screen by Next Generation Sequencing with Fragile X
Myriad Women's Health
